| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00023 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.00014 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.00012 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -1.6e-05 | 1 |